What happens if.....

Hi Guys,

Im relatively new to PAR, and investing in pharmaceutical companies. I bought in at $1.71 and topped up at around $2.3.

I decided to invest in Paradigm based on 3 things.

1. Advice from someone I trust, and learnings from some of the reading he gave me.

2. The product itself, and the fact that it could be seen as the number one treatment for OA if approved.

3. The potential upside of where the SP could go if granted FDA approval based on where I bought in.

And it’s that third point Id like to ask you all about.

We are all smart enough to know that approval by the FDA is by no means a given and that in fact is reflected in the current SP. If it does get approved then there has been much talk about the SP being x20, x50 even x100. But what happens if it doesn’t get approved at the end of 2022 / Phase 3 trials. What do you all think that would do to the SP?

Would Paradigm get another chance at clinical trials? would all confidence by investors be lost? Ive been told that any investment would be worth 20x or zero based on those trials…have any of you had experience where approvals have not been granted and if so what happened next?

I apologise if this has already been covered at an earlier point.

Thanks for all you input on the PAR thread, especially such people as @Griffin007 @edski1 @PharmD and @Mozzarc among others.

Any thoughts most welcome.